For example, arsenic trioxide (As2O3, Trisenox®) has been used as standard monotherapy in acute promyelocytic leukemia (APL), which is a rare case of acute myeloid leukemia (AML), targeting the PML/RARA oncogene7,8. This evidence concerns the gene RARA and acute myeloid leukemia.